Capital Advisors, Ltd. LLC Repligen Corp Transaction History

Capital Advisors, Ltd. LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$120.0 - $182.95 $360 - $548	3 New	3 $0
Q3 2023 Oct 27, 2023	BUY	$138.78 - $176.51 $277 - $353	2 New	2 $0
Q4 2022 Feb 07, 2023	SELL	$162.42 - $220.56 $1,136 - $1,543	-7 Reduced 35.0%	13 $2,000
Q3 2022 Nov 09, 2022	BUY	$160.42 - $256.21 $1,122 - $1,793	7 Added 53.85%	20 $4,000
Q2 2022 Aug 05, 2022	BUY	$140.68 - $188.02 $1,266 - $1,692	9 Added 225.0%	13 $2,000
Q1 2022 May 09, 2022	BUY	$161.19 - $257.96 $483 - $773	3 Added 300.0%	4 $1,000
Q4 2021 Feb 08, 2022	BUY	$247.59 - $304.47 $247 - $304	1 New	1 $0

479

54.9M

297K

343K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.